Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

GPS collars 'can monitor response to treatment'
Collie Max with GPS collar
Edinburgh vets hope to use GPS collars in future to learn more about how physical activity affects disease.

Vets study the effect of medication on dogs with osteoathritis

GPS technology could be used by vets to monitor the effects of certain medications. In a recent study, Edinburgh vets used GPS collars to determine the effects of painkillers in dogs with osteoarthritis.

Using the technology, vets from the Royal (Dick) School of Veterinary Studies were able to compare the movements of healthy dogs, to those of dogs with osteoarthritis.

According to their findings, published in the journal PLOS One, dogs treated with the anti-inflammatory painkiller Carprofen could run in nearly the same way as healthy dogs.

Lead researcher Dr Dylan Clements, said: "GPS collars have given us an insight into the levels of physical performance dogs exhibit during their normal daily activities, and show us how much we can alter a dog’s performance by keeping them on or off a lead, or playing with them.
 
"We found that they were a sensitive way for us to measure how well dogs recover from a disease that affects activity, such as osteoarthritis. We hope to be able to use the collars to understand more about how activity might contribute to or help prevent diseases in the future."

The collars allowed vets to monitor how quickly the dogs moved and changed speed, as well as how far they travelled during their normal exercise regime.

According to data collected from the collars, the dogs with osteoarthritis were able to run as quickly as healthy dogs, but their condition significantly affected their ability to speed up and slow down.

When they were treated with Carprofen, however, their performance improved to a level comparable to that of the healthy dogs for most of the measures taken during the study.

To view the research, visit: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0117094
 

Image © Dr Stephen Ellwood, Royal (Dick) School of Veterinary Studies

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.